	Evaluating datopotamab deruxtecan (Dato-DXd) as a novel treatment option for EGFR-mutated non-small cell lung cancer. Future Oncol Tsvetkova O, Gil TE, Kassir G, Castanon S, Kollapaneni SS, Han A, Park SJ, Li R, Velez MA, Lisberg AE. PMID: 42345080 [PubMed - as supplied by publisher]
	Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs. Front Immunol Mao W, Tang Z, Chen Y, Chen Y, Zhang S, Feng X, Zhang S. PMID: 42344916 [PubMed - indexed for MEDLINE]
	Prognostic utility of circulating tumor DNA assessment in immune checkpoint inhibitor-treated advanced non-small cell lung cancer: a systematic review and meta-analysis. Front Immunol Wang Y, Wu S, Wei Y, Fan S, Xu Z, Li D, Teng Z, Wang J. PMID: 42344896 [PubMed - indexed for MEDLINE]
	Spatiotemporal heterogeneity in non-small cell lung cancer: A paradigm shift from characterization to dynamic management (Review). Oncol Lett Cao L, Zhang W. PMID: 42344719 [PubMed]
	Low-input CSF cfDNA shallow whole-genome sequencing for CNV-based diagnosis and monitoring of leptomeningeal metastasis in lung cancer. Acta Neuropathol Commun Guan X, Li Y, Shi Z, An J, Hua Y, Ding X, Zheng X, Xu W, Zhang D, Xue Z, Kang P, Cao D, Li X, Jia W. PMID: 42343476 [PubMed - as supplied by publisher]
	Therapeutic outcomes of PD-1 blockade-related regimens versus docetaxel in previously immunotherapy-treated advanced non-small cell lung cancer: a retrospective, exploratory study. BMC Cancer Huang TT, Wang XY, Li Q, Song PF. PMID: 42343297 [PubMed - as supplied by publisher]
	Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial. Nat Med Huang Z, Zeng L, Ruan Z, Zeng Q, Yan H, Jiang W, Xiong Y, Zhou C, Yang H, Liu L, Dai J, Zou N, Xu S, Wang Y, Wang Z, Deng J, Chen X, Wang J, Xiang H, Li X, Duchemann B, Chen G, Xia Y, Mok T, Scheiermann C, Lévi F, Yang N, Zhang Y. PMID: 42343117 [PubMed - as supplied by publisher]
	The clinicoradiological and pathological-molecular characteristics associated with spread through air spaces in stage IA invasive lung adenocarcinoma. Insights Imaging Xu F, Li X, Zhao WH, Huo JW, Luo TY, Li Q. PMID: 42342956 [PubMed]
	Interpretable machine learning for preoperative prediction of ground-glass nodules invasiveness in lung adenocarcinoma: a multicenter study. Sci Rep Wu Z, Li L, Shi D, Xiao Y. PMID: 42342788 [PubMed - as supplied by publisher]
	Multimodal PET/CT-based PD-L1 status prediction in lung cancer via semi-supervised and unsupervised deep learning. Sci Rep Da-Ano R, Tankyevych O, Lucia F, Duysinx B, Lallemand F, Hustinx R, Lovinfosse P, Le Rest CC, Visvikis D. PMID: 42342763 [PubMed - as supplied by publisher]
	Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study. J Immunother Cancer de Joode K, Groen HJ, Heuvel MVD, Kloover JS, Van Der Meer F, Van der Leest CH, Van Den Borne B, De Wijn R, Hurkmans DP, Van den Heuvel DMA, Pinedo HM, Kapiteijn E, Debets R, Verdegaal EME, Van der Burg SH, Groten JP, Aerts JGJV, Mathijssen RHJ. PMID: 42342406 [PubMed - indexed for MEDLINE]
	Supporting nurses to improve clinical trial discussions with patients with lung cancer using the Lung I-ACT tool: a mixed methods pilot study. BMJ Open Respir Res Lond B, Dodd C, Davey Z, Williamson IR, Rawlinson J, McPhelim J, Darlison L, Henshall C. PMID: 42342292 [PubMed - indexed for MEDLINE]
	Germline Variants and Impact on Lung Cancer Outcomes Following Chemotherapy: A Systematic Review. Crit Rev Oncol Hematol Al-Matrafi AR, Baxter MA, Pearson ER, Petty RD. PMID: 42342141 [PubMed - as supplied by publisher]
	Brief Report: Proposed clinical trial guidelines based on clinicopathological heterogeneity of metastatic pulmonary large cell neuroendocrine carcinoma (LCNEC). J Thorac Oncol Choudhury NJ, Gezelius E, Arfe A, Baine M, Falcon CJ, Yu H, Rekhtman N, Rudin CM. PMID: 42341877 [PubMed - as supplied by publisher]
	Targeting HDAC2 with Bruceine D epigenetically restores SMAD3 expression via H4K16ac enrichment to suppress malignant progression in EGFR-TKI-resistant lung adenocarcinoma. J Ethnopharmacol Wang K, Wu Z, Lu B, Tao X, Chen P, Lu T, Gao M, Zhang H, Song Y, Ke X. PMID: 42341853 [PubMed - as supplied by publisher]
	Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: A European and East Asian Populations-Based Mendelian Randomization Analysis. Cancer Res Treat Ying F, Zhao X, Wang T. PMID: 42341840 [PubMed - as supplied by publisher]
	Sex disparities in lung cancer: Results of the KBP-2020-CPHG study. Lung Cancer Templement-Grangerat D, Locher C, Neidhardt AC, Fore M, Auvray E, Sabatini M, Goarant É, Bigot F, Lefoll C, Delmas C, Maetz E, Picaud M, Delafosse C, Christiann F, Marichy C, Pante V, Bordier S, Di Meglio F, Morel H, Debieuvre D, Study Group KBP-2020-CPHG. PMID: 42341535 [PubMed - as supplied by publisher]
	Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population. JCO Glob Oncol Choucair K, Bazzi H, Abda F, Harb F, Snounu Y, Ong V, Chen W, Barton C, Mamdani H, Gadgeel SM, Al Achkar M. PMID: 42341251 [PubMed - indexed for MEDLINE]
	Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918). JCO Glob Oncol Mascarenhas E, Gelatti ACZ, Montella T, Corassa M, William WN Jr, Yamamura R, Baldotto C, Cronemberger EH, Calabrich AFC, Borges GS, Teixeira CHA, Matias D, Fares AF, Sampaio CDAT, Gazola AA, Zuanazzi FC, Schulze PAC, Franche LMT, de Jesus RG, Giacomazzi J, Rocha MS, Gössling G, Ferreira CG. PMID: 42341249 [PubMed - indexed for MEDLINE]
	Adenosquamous carcinoma of the lung: Comparative CT and pathological features versus adenocarcinoma and squamous cell carcinoma. PLoS One Yuan Q, Zhang D, Xu R, Yao W, Zhao H. PMID: 42341017 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 160730

Page 1 of 8037



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy